Impact of microparticles derived from erythrocytes on fibrinolysis

Grigory Levin1, Ekaterina Sukhareva2, Athina Lavrentieva3

  • 1Federal State Budgetary Institution "Privolzhsky Federal Research Medical Centre" of the Ministry of Health of the Russian Federation, 18, Verhne-Volzhskaya Naberezhnaya, Nizhny Novgorod, Russia, 603155. levin@unn.ac.ru.

Insights

Erythrocyte microparticles exhibit significant fibrinolytic activity, primarily due to plasminogen. This activity diminishes as red blood cells are stored, impacting blood product safety.

Area of Science:

  • Hematology
  • Biochemistry
  • Thrombosis and Hemostasis

Background:

  • Erythrocyte-derived microparticles (EMPs) are known for procoagulant activity.
  • Fibrinolytic activity of EMPs is less understood, especially during red blood cell storage.
  • Increased EMPs during storage raise concerns about their hemostatic balance.

Purpose of the Study:

  • To investigate the fibrinolytic activity of EMPs.
  • To determine the impact of red blood cell storage duration on EMP fibrinolytic potential.
  • To elucidate the mechanisms underlying EMP-associated fibrinolysis.

Main Methods:

  • Isolation of EMPs from stored erythrocytes at various time points (7, 14, 21, 28 days).
  • Assessment of EMPs' effect on plasma fibrinolytic activity using coagulation assays.
  • Evaluation of EMPs' interaction with chromogenic substrates and plasminogen.

Main Results:

  • EMPs demonstrate significant fibrinolytic activity, cleaving fibrin and chromogenic substrates.
  • Plasminogen adsorbed onto EMPs is the primary driver of their fibrinolytic capacity.
  • EMPs enhance streptokinase-plasminogen complex activity but have a lesser effect on euglobulin clot lysis time.
  • Fibrinolytic activity of EMPs decreases notably with prolonged erythrocyte storage.

Conclusions:

  • Erythrocyte-derived microparticles possess inherent and significant fibrinolytic properties.
  • The fibrinolytic potential of EMPs is largely attributed to bound plasminogen.
  • Storage of red blood cells leads to a decline in the fibrinolytic activity of EMPs.

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.4K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.9K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.7K